Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02682056 · ClinicalTrials.gov registry record · NA

Glucose Measurement Using Microneedle Patches

A NA study of Diabetes, sponsored by Emory University.

Completed
Registry status
NA
Development phase
15
Enrollment target
2
Study locations

NCT02682056 is a NA study of Diabetes that has completed, run by Emory University. The registered enrollment target is 15 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02682056, a NA study of Diabetes, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
2
Study locations

Study Summary

This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels among the diabetic pediatric population.

Conditions Studied

Interventions

  • DEVICE Microneedle patch
  • DEVICE Intravenous (IV) catheter
  • DEVICE Lancet

Study Locations (2)

Georgia

  • Children's Healthcare of Atlanta - Atlanta
  • Emory Children's Center - Atlanta

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2017-12-21
Est. Completion 2018-01-29
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02682056

The ClinicalTrials.gov registry entry for NCT02682056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Microneedle patch is the first listed.

NCT02682056 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02682056 about?

NCT02682056 is a clinical study titled "Glucose Measurement Using Microneedle Patches". This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels a...

What is the current status of trial NCT02682056?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-12-21. Estimated completion is 2018-01-29.

What conditions does trial NCT02682056 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT02682056?

The interventions under investigation include: Microneedle patch (DEVICE), Intravenous (IV) catheter (DEVICE), Lancet (DEVICE).

Who is sponsoring clinical trial NCT02682056?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02682056 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.